Compared with standard flu shots, Moderna’s mFlusiva generates stronger, longer-lasting immunity and is more effective at preventing infection, data show.
For older adults, the flu vaccine could look a little different this year.
Morning Overview on MSN
The FDA approved the first mRNA flu vaccine for adults 50 and older
The Food and Drug Administration has approved the first influenza vaccine built on messenger RNA technology, the same ...
The Food and Drug Administration just approved the new type of flu vaccine for adults ages 50 and older. It relies on the same technology as many Covid-19 jabs. However, it’s unclear whether insurance ...
The shot, made by Moderna, will be available for this year's upcoming flu season.
In light of recent wins for mRNA vaccine makers, UCSC RNA Center Co-Director Jeremy Sanford describes the versatility of the ...
The Food and Drug Administration has approved the first-ever mRNA flu vaccine, a shot that will use new technology to target evolving viruses and streamline vaccine production faster than traditional ...
Just The News on MSNOpinion
From 'measles-associated' deaths to new COVID vaccines, doubts mount based on absence of evidence
Pennsylvania governor criticized across the poltical spectrum for overstating certainty, hiding information about deaths he ...
The US Food and Drug Administration on Wednesday approved the United States’ first mRNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results